Excerpt: “Samsung C&T is riding the wave with Samsung Biologics’ performance boost, while SK Square is killing it with a big jump in operating profits thanks to the semiconductor boom,” said Park Sang-hyun , an analyst at SmartKarma , a Singapore-based …
koreatimes.co.kr • (Opens in a new window) ⧉
Are you a Professional Journalist?
The Smartkarma Press Pass is a special login created exclusively for pre-approved professional journalists. It allows a journalist to access content on the platform and use all the powerful search and discovery functionality available. Journalists can excerpt and quote from the content on Smartkarma to enrich and support their articles.
